Phase III Randomized Study of the Inhalation of Tobramycin in Patients With Cystic Fibrosis
Status:
Completed
Trial end date:
1998-05-01
Target enrollment:
Participant gender:
Summary
OBJECTIVES: I. Determine the safety and efficacy of tobramycin in patients with cystic
fibrosis who are chronically colonized with Pseudomonas aeruginosa.
II. Determine whether this treatment produces tobramycin-resistant bacteria at a frequency
different from the placebo group and whether the emergence of resistance is associated with a
lack of clinical response.